Document is current
Any future updates will be listed below
-
Authors
Mathen, Caroline https://orcid.org/0000-0002-6324-9845
Dsouza, Wilfrid https://orcid.org/0000-0002-4068-1264
Sharma, Deepali https://orcid.org/0009-0006-7776-0106
Pradhan, Trupti Ninad https://orcid.org/0000-0001-5491-2070
Kesarwani, Apeksha
Gujar, Divya
Choudhary, Mangi Lal https://orcid.org/0009-0008-5707-3637
Nithyanand, Aishwarya https://orcid.org/0000-0003-3271-4617
Ghosalkar, Rutika https://orcid.org/0009-0003-4531-4732
Ingle, Arvind https://orcid.org/0000-0001-9201-9224
Chaudhari, Pradip https://orcid.org/0000-0002-6792-7658
Goda, Jayant Sastri https://orcid.org/0000-0002-3915-8927
Kode, Jyoti https://orcid.org/0000-0001-6907-2449
-
Funding
Funding for this research was provided by:
OCT Therapies and Research Pvt Ltd. (5210)
- License Information
-
More Information
Article History
Received: 9 October 2025
Accepted: 11 February 2026
First Online: 24 February 2026
Declarations
:
: Caroline Mathen is the Director of OCT Therapies and Research Pvt Ltd.The other authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
: 1. The study approved by Institutional Animal Ethics Committee (IAEC) of the test facility under the project title "Repeated Dose 28 Day Oral Toxicity Study in Rat" on July 06, 2023 (JDM/IAEC/2022/03/115). 2. The study was approved by Institutional Animal Ethics Committee (IAEC) of the test facility under the project title "Repeated Dose 28 Day Oral Toxicity Study in Mice" on July 06, 2023 (JDM/IAEC/2023/02/087 and JDM/IAEC/2023/02/088). 3. The study was approved by the Institutional Animals Ethics Committee [(IAEC Proposal No.SF_23_55_001) (23_657)] under the project title “Evaluation of efficacy of an indigenously prepared topical formulation containing Mesenchymal Stromal Cell Conditioned Media for prevention/mitigation of chemotherapy induced oral mucositis”. 4. The study was approved by the Institutional Animals Ethics Committee (IAEC) project # 46/2022 under the project title “Evaluation of efficacy of an indigenously prepared topical formulation containing mesenchymal stem cell conditioned media for prevention/ mitigation of radiotherapy induced toxicity”. 5. Authors confirm that the study was conducted and reported in accordance with ARRIVE guidelines.
: This work is protected under PCT/IN2018/050078.
